| scholarly article | Q13442814 |
| P50 | author | Erwin G. Van Meir | Q30503507 |
| P2093 | author name string | Gang Chen | |
| Daniel J Brat | |||
| Jeffrey J Olson | |||
| Nigel Mackman | |||
| Vladimir E Belozerov | |||
| Donald L Durden | |||
| Carol Tucker-Burden | |||
| Yuan Rong | |||
| P2860 | cites work | Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. | Q27824850 |
| Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma | Q27860910 | ||
| PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer | Q27860985 | ||
| Regulation of the tissue factor gene | Q28293617 | ||
| Differential regulation and properties of MAPKs | Q28301932 | ||
| Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers | Q28306997 | ||
| Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors | Q29547596 | ||
| The phosphatidylinositol 3-Kinase AKT pathway in human cancer | Q29547860 | ||
| AP-1 as a regulator of cell life and death | Q29616558 | ||
| High-resolution global genomic survey of 178 gliomas reveals novel regions of copy number alteration and allelic imbalances | Q33259264 | ||
| Signaling by the germinal center kinase family of protein kinases | Q33534707 | ||
| Extrinsic-pathway activation in cancer with high factor VIIa and tissue factor | Q34057583 | ||
| Molecular basis for the relationship between thrombosis and cancer | Q34342948 | ||
| Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification | Q34350623 | ||
| Targeting the PI3K-Akt pathway in human cancer: rationale and promise | Q35571372 | ||
| A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity | Q35660849 | ||
| Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma | Q35678312 | ||
| Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms | Q35850648 | ||
| Tissue factor is required for uterine hemostasis and maintenance of the placental labyrinth during gestation | Q36417683 | ||
| 'Pseudopalisading' necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis | Q36510818 | ||
| NF-kappaB and cancer-identifying targets and mechanisms | Q36984251 | ||
| Intravascular thrombosis in central nervous system malignancies: a potential role in astrocytoma progression to glioblastoma | Q37029795 | ||
| Induction of tissue factor expression in human endothelial cells by CD40 ligand is mediated via activator protein 1, nuclear factor kappa B, and Egr-1. | Q38289775 | ||
| Early growth response gene-1 regulates hypoxia-induced expression of tissue factor in glioblastoma multiforme through hypoxia-inducible factor-1-independent mechanisms | Q38311379 | ||
| EGFR tyrosine kinase inhibitors decrease VEGF expression by both hypoxia-inducible factor (HIF)-1-independent and HIF-1-dependent mechanisms | Q38314949 | ||
| A short N-terminal sequence of PTEN controls cytoplasmic localization and is required for suppression of cell growth | Q40184782 | ||
| Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas | Q40383820 | ||
| PTEN and hypoxia regulate tissue factor expression and plasma coagulation by glioblastoma. | Q40453813 | ||
| Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis | Q40502054 | ||
| Human Bcl-2 activates ERK signaling pathway to regulate activating protein-1, lens epithelium-derived growth factor and downstream genes. | Q40522883 | ||
| Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population | Q40590816 | ||
| Elevated JNK activation contributes to the pathogenesis of human brain tumors | Q42524158 | ||
| Identification of the JNK signaling pathway as a functional target of the tumor suppressor PTEN. | Q42807109 | ||
| Regulation of angiogenesis by tissue factor cytoplasmic domain signaling | Q44034416 | ||
| PTEN mutations in gliomas and glioneuronal tumors. | Q47995275 | ||
| Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain | Q48583425 | ||
| Expression of tissue factor correlates with grade of malignancy in human glioma. | Q55479707 | ||
| Patient age, histologic features, and length of survival in patients with glioblastoma multiforme. | Q55487073 | ||
| In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease | Q70934414 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | glioblastoma | Q282142 |
| P304 | page(s) | 2540-2549 | |
| P577 | publication date | 2009-03-10 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Epidermal growth factor receptor and PTEN modulate tissue factor expression in glioblastoma through JunD/activator protein-1 transcriptional activity | |
| P478 | volume | 69 |
| Q33431673 | A critical balance: managing coagulation in patients with glioma |
| Q54967623 | Association between oncogenic status and risk of venous thromboembolism in patients with non-small cell lung cancer. |
| Q38805415 | Biological basis of personalized anticoagulation in cancer: oncogene and oncomir networks as putative regulators of coagulopathy |
| Q34463432 | Brain neoplasms and coagulation-lessons from heterogeneity |
| Q39250608 | Cancer cells induced to express mesenchymal phenotype release exosome-like extracellular vesicles carrying tissue factor |
| Q38642557 | Cancer-associated pathways and biomarkers of venous thrombosis |
| Q57824763 | Cancer-associated thrombosis: The search for the holy grail continues |
| Q47874491 | Characterization of a FOXG1:TLE1 transcriptional network in glioblastoma initiating cells. |
| Q44444427 | Coagulation-related gene expression profile in glioblastoma is defined by molecular disease subtype |
| Q55457269 | Combination of isocitrate dehydrogenase 1 (IDH1) mutation and podoplanin expression in brain tumors identifies patients at high or low risk of venous thromboembolism. |
| Q98623166 | Combined treatment with CBP and BET inhibitors reverses inadvertent activation of detrimental super enhancer programs in DIPG cells |
| Q36280796 | Complex oncogenic signaling networks regulate brain tumor-initiating cells and their progenies: pivotal roles of wild-type EGFR, EGFRvIII mutant and hedgehog cascades and novel multitargeted therapies |
| Q93271536 | Crosstalk between TF/FVIIa and EGFR signaling in colorectal cancer cells |
| Q34101190 | Detection of "oncometabolite" 2-hydroxyglutarate by magnetic resonance analysis as a biomarker of IDH1/2 mutations in glioma |
| Q36808787 | Epidermal growth factor receptor variant type III markedly accelerates angiogenesis and tumor growth via inducing c-myc mediated angiopoietin-like 4 expression in malignant glioma |
| Q93369514 | Exposure of the extracellular matrix and colonization of the ovary in metastasis of fallopian-tube-derived cancer |
| Q98183400 | Genes and proteins associated with the risk for cancer-associated thrombosis |
| Q98183420 | Genetic and epigenetic regulation of cancer coagulome - lessons from heterogeneity of cancer cell populations |
| Q84340559 | Genetic pathways linking hemostasis and cancer |
| Q38535581 | Glioblastoma complicated by fatal malignant acute ischemic stroke: MRI finding to assist in tricky surgical decision |
| Q34052754 | Human Brat ortholog TRIM3 is a tumor suppressor that regulates asymmetric cell division in glioblastoma |
| Q35164701 | Hypoxia triggers a proangiogenic pathway involving cancer cell microvesicles and PAR-2-mediated heparin-binding EGF signaling in endothelial cells. |
| Q47584260 | Identifying radiographic specificity for phosphatase and tensin homolog and epidermal growth factor receptor changes: a quantitative analysis of glioblastomas |
| Q37459120 | Immunohistochemical classification of primary and secondary glioblastomas |
| Q38051761 | Interleukins in glioblastoma pathophysiology: implications for therapy. |
| Q91859000 | Methylation-dependent Tissue Factor Suppression Contributes to the Reduced Malignancy of IDH1-mutant Gliomas |
| Q42364589 | Molecular imaging using an anti-human tissue factor monoclonal antibody in an orthotopic glioma xenograft model |
| Q38214950 | Oncogenes and the coagulation system--forces that modulate dormant and aggressive states in cancer |
| Q38017366 | Oncogenic regulation of tissue factor and thrombosis in cancer |
| Q36088261 | Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells. |
| Q41864823 | P14ARF suppresses tumor-induced thrombosis by regulating the tissue factor pathway. |
| Q36899519 | PI3K p110β isoform synergizes with JNK in the regulation of glioblastoma cell proliferation and migration through Akt and FAK inhibition |
| Q41709078 | Pathological expression of tissue factor confers promising antitumor response to a novel therapeutic antibody SC1 in triple negative breast cancer and pancreatic adenocarcinoma |
| Q91979008 | Pathophysiology 1. Mechanisms of Thrombosis in Cancer Patients |
| Q35766780 | Photodynamic therapy-induced angiogenic signaling: consequences and solutions to improve therapeutic response |
| Q98163640 | PiggyBac mutagenesis and exome sequencing identify genetic driver landscapes and potential therapeutic targets of EGFR-mutant gliomas |
| Q55513456 | Prognostic stratification of adult primary glioblastoma multiforme patients based on their tumor gene amplification profiles. |
| Q41593075 | Prognostic values of tissue factor and its alternatively splice transcripts in human gastric cancer tissues |
| Q37942473 | Protease-activated receptor 2 signaling in inflammation |
| Q34450747 | Protease-activated receptors mediate crosstalk between coagulation and fibrinolysis |
| Q53781843 | Prothrombotic state in glioblastoma multiforme: an evaluation of the procoagulant activity of circulating microparticles. |
| Q35729814 | Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320 |
| Q55464074 | Role of the tissue factor pathway in the biology of tumor initiating cells. |
| Q39160971 | TF/FVIIa/PAR2 promotes cell proliferation and migration via PKCα and ERK-dependent c-Jun/AP-1 pathway in colon cancer cell line SW620. |
| Q36103845 | Targeting JNK for therapeutic depletion of stem-like glioblastoma cells |
| Q89640197 | The EGFR-rearranged adenocarcinoma is associated with a high rate of venous thromboembolism |
| Q27015045 | The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered |
| Q33402515 | The therapeutic management of bleeding and thrombotic disorders complicating CNS malignancies |
| Q35967008 | The tumor microenvironment strongly impacts master transcriptional regulators and gene expression class of glioblastoma |
| Q33688466 | Tissue Factor promotes breast cancer stem cell activity in vitro. |
| Q37903955 | Tissue factor and cell signalling in cancer progression and thrombosis |
| Q33672303 | Tissue factor associates with survival and regulates tumour progression in osteosarcoma. |
| Q37628002 | Tissue factor expression provokes escape from tumor dormancy and leads to genomic alterations |
| Q34544801 | Tissue factor in tumor microenvironment: a systematic review |
| Q33710071 | Tumors, ticks and tissue factor |
| Q35005521 | Upregulation of tissue factor by activated Stat3 contributes to malignant pleural effusion generation via enhancing tumor metastasis and vascular permeability in lung adenocarcinoma |
| Q30436810 | Venous thromboembolism in malignant gliomas |
Search more.